RPX7009

· Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RPX7009, covering 2013-07-11 to 2014-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects [Phase 1]